| P50 | author | Fabien Gosselet | Q38801251 |
| | Markus M Forsberg | Q59161834 |
| | Kati-Sisko Vellonen | Q73203263 |
| | Tarja Malm | Q81269165 |
| P2093 | author name string | Jari Koistinaho | |
| | Marika Ruponen | |
| | Katja M Kanninen | |
| | Jouni Ihalainen | |
| | Anthony R White | |
| | Marie-Christine Boucau | |
| | Mikko Gynther | |
| | Théo Picardat | |
| P2860 | cites work | Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice | Q22242267 |
| | Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase | Q28188098 |
| | Processing of gene expression data generated by quantitative real-time RT-PCR. | Q30699578 |
| | Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain | Q33208179 |
| | Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 |
| | Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors | Q83364209 |
| | Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats | Q87298064 |
| | Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease | Q33862071 |
| | GFAP in health and disease. | Q34158294 |
| | Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. | Q34353553 |
| | Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice | Q35996449 |
| | Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. | Q36949815 |
| | Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. | Q37216153 |
| | ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. | Q37351212 |
| | Profiling solute carrier transporters in the human blood-brain barrier | Q37529321 |
| | Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner | Q37656600 |
| | The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain | Q37663394 |
| | Review: Cerebral microvascular pathology in ageing and neurodegeneration | Q37800161 |
| | Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position. | Q38099191 |
| | Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). | Q38295848 |
| | Drug transporters in the central nervous system | Q38342677 |
| | ABC efflux transporters in brain vasculature of Alzheimer's subjects | Q42930763 |
| | Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption | Q43081590 |
| | Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease | Q43707054 |
| | Characterization of methotrexate transport and its drug interactions with human organic anion transporters | Q44072251 |
| | Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain. | Q45970954 |
| | Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants | Q46461155 |
| | Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1). | Q46482976 |
| | Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. | Q46503083 |
| | Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus | Q47739726 |
| | An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter. | Q47967419 |
| | In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy | Q48294616 |
| | Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans | Q48476417 |
| | Co-expression of multiple transgenes in mouse CNS: a comparison of strategies | Q48889458 |
| | ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy. | Q48925149 |
| | Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy | Q49409019 |
| | Blood-brain barrier P-glycoprotein function in Alzheimer's disease. | Q50778486 |
| | Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier. | Q51027620 |
| | Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies. | Q52147644 |
| | An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis | Q53314247 |
| | Alzheimer's disease | Q55880664 |
| | The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain | Q71485735 |
| P433 | issue | 12 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | drug discovery | Q1418791 |
| P304 | page(s) | 2652-2662 | |
| P577 | publication date | 2017-09-26 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla | |
| P478 | volume | 34 | |